| Market Cap | ₹2.71Cr |
| ROE | 18.25% |
| P/E Ratio(TTM) | -19.57 |
| EPS(TTM) | -0.23 |
| P/B Ratio | 0.00 |
| Dividend Yield | 0.00% |
| Industry P/E | 40.32 |
| Book Value | -1.25 |
| Debt to Equity | -1.08 |
| Face Value | 5 |
| Parent Organisation | Rekvina Laboratories Limited |
| Managing Director | Amit Mukesh Shah |
| Founded | 1988 |
| BSE Symbol | 526075 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 58.80 | ||
| Ajanta Pharma | NA (0.00%) | 33.44 | ||
| Gland Pharma | NA (0.00%) | 36.89 | ||
| Eris Lifesciences | NA (0.00%) | 47.39 |